Influenza viruses antagonize key immune defence mechanisms via the virulence factor non-structural protein 1 (NS1). A key mechanism of virulence by NS1 is blocking nuclear export of host messenger RNAs, including those encoding immune factors [1] [2] [3] ; however, the direct cellular target of NS1 and the mechanism of host mRNA export inhibition are not known. Here, we identify the target of NS1 as the mRNA export receptor complex, nuclear RNA export factor 1-nuclear transport factor 2-related export protein 1 (NXF1-NXT1), which is the principal receptor mediating docking and translocation of mRNAs through the nuclear pore complex via interactions with nucleoporins 4, 5 . We determined the crystal structure of NS1 in complex with NXF1-NXT1 at 3.8 Å resolution. The structure reveals that NS1 prevents binding of NXF1-NXT1 to nucleoporins, thereby inhibiting mRNA export through the nuclear pore complex into the cytoplasm for translation. We demonstrate that a mutant influenza virus deficient in binding NXF1-NXT1 does not block host mRNA export and is attenuated. This attenuation is marked by the release of mRNAs encoding immune factors from the nucleus. In sum, our study uncovers the molecular basis of a major nuclear function of influenza NS1 protein that causes potent blockage of host gene expression and contributes to inhibition of host immunity.
Influenza viruses antagonize key immune defence mechanisms via the virulence factor non-structural protein 1 (NS1). A key mechanism of virulence by NS1 is blocking nuclear export of host messenger RNAs, including those encoding immune factors [1] [2] [3] ; however, the direct cellular target of NS1 and the mechanism of host mRNA export inhibition are not known. Here, we identify the target of NS1 as the mRNA export receptor complex, nuclear RNA export factor 1-nuclear transport factor 2-related export protein 1 (NXF1-NXT1), which is the principal receptor mediating docking and translocation of mRNAs through the nuclear pore complex via interactions with nucleoporins 4, 5 . We determined the crystal structure of NS1 in complex with NXF1-NXT1 at 3.8 Å resolution. The structure reveals that NS1 prevents binding of NXF1-NXT1 to nucleoporins, thereby inhibiting mRNA export through the nuclear pore complex into the cytoplasm for translation. We demonstrate that a mutant influenza virus deficient in binding NXF1-NXT1 does not block host mRNA export and is attenuated. This attenuation is marked by the release of mRNAs encoding immune factors from the nucleus. In sum, our study uncovers the molecular basis of a major nuclear function of influenza NS1 protein that causes potent blockage of host gene expression and contributes to inhibition of host immunity.
More than 100 years after the deadly Spanish flu pandemic that caused around 30 million deaths worldwide, influenza virus remains a major public health threat, resulting in 250,000-500,000 deaths annually [6] [7] [8] . Influenza A virus is a negative-stranded RNA virus with an eight-segmented genome. Transcription and genome replication of influenza A virus take place in the host cell nucleus. Accordingly, influenza A virus has evolved strategies to exploit host nuclear functions. A prominent example is inhibition of export of host messenger RNAs from the nucleus to the cytoplasm by influenza A infection 1, 2 , but the underpinning mechanism is largely unknown. Virus virulence depends on inhibition of mRNA export, as this prevents expression of mRNAs encoding antiviral factors 1, 2 . mRNA nuclear export through the nuclear pore complex (NPC) is the culmination of the nuclear phase of eukaryotic gene expression 4, 5 . To become export competent, mRNA needs to acquire the principal mRNA export receptor, the nuclear RNA export factor 1-nuclear transport factor 2-related export protein 1 (NXF1-NXT1) heterodimer, the role of which is to facilitate mRNA translocation through the NPC. Binding and release of NXF1-NXT1 governs the direction of the mRNA transport, and these events are spatiotemporally regulated through two DEAD-box ATPases, 56 kDa U2AF-associated protein (UAP56) in the nucleus and DEAD-box helicase19 (DDX19) at the cytoplasmic face of the NPC. Moreover, NXF1-NXT1 interacts with phenylalanine-glycine (FG) repeats of nucleoporins. Binding of NXF1-NXT1 to FG nucleoporins is required for NPC docking and translocation of mRNAs through the highly concentrated FG milieu occupying the central NPC channel 4, 5, 9 . The virulence factor non-structural protein 1 (NS1) of influenza A virus inhibits host mRNA nuclear export [1] [2] [3] . This effect contributes to NS1-mediated inhibition of host immunity 1, 2 . NS1 suppresses host antiviral response by inhibiting signal transduction and gene expression at multiple levels 10 . It has been shown to target the host mRNA 3′-processing machinery including CPSF30 and PABII 11, 12 . With respect to inhibition of mRNA nuclear export, we have previously shown NS1 interaction with the mRNA export machinery, including NXF1-NXT1, Rae1 and E1B-AP5. The blockage of mRNA export by NS1 was rescued by ectopic expression of NXF1-NXT1 1 . However, the direct target of NS1 within the mRNA export machinery and the molecular mechanism involved in the mRNA nuclear export blockage have not been resolved.
Using recombinant purified proteins in an in vitro binding assay, we show that NS1 from influenza A/Texas/36/91 virus, a human seasonal H1N1 strain, directly interacts with two domains of the mRNA export receptor NXF1: the nucleoporin-binding domain (NTF2L) and the leucine-rich repeat domain (LRR) (Fig. 1a,b and Supplementary Fig. 1 ). Ectopic expression of NXF1 domains containing the NS1-binding regions (NXF1 residues 201-619) or lacking the NS1-binding site (NXF1 residues 1-200) was performed in human bronchial epithelial cells (HBECs) infected with influenza virus to determine their impact on poly(A) RNA distribution. Immunofluorescence microscopy detected NXF1 proteins and RNA fluorescence in situ hybridization (FISH) was used to monitor poly(A) RNA and viral M mRNA distribution to select for infected cells (Fig. 1c-e and Supplementary Fig. 2 ). As expected, influenza virus infection resulted in retention of poly(A) RNA in the nucleus, as shown by the increase in nuclear-to-cytoplasmic ratios of poly(A) RNA without major changes in total poly(A) RNA levels ( Fig. 1c-e) . We then showed that expression of full-length NXF1 or the NS1-binding region of NXF1 (residues 201-619) rescued the mRNA-export block induced by influenza virus infection (Fig. 1c-e) . However, NXF1 lacking the NS1-binding site (residues Letters Nature Microbiology had no effect on this viral-mediated block and did not alter poly(A) RNA distribution when expressed in the absence of infection ( Fig. 1c-e) . Together, these results suggest that interaction of NS1 with overexpressed NXF1 containing the NS1-binding site released endogenous NXF1 to exert its function on nuclear export of poly(A) RNA.
To investigate the molecular determinants of NS1-NXF1-NXT1 recognition, we solved a crystal structure of the complex. Untagged full-length NS1 is prone to aggregation in solution. Mutant NS1(R38A/K41A), which suppresses NS1 aggregation but lacks RNA-binding activity 13, 14 , was used for crystallization, as the interaction between NS1 and NXF1-NXT1 does not require RNA (Fig. 1b) . We initially obtained poorly diffracting crystals using NS1(R38A/ K41A) and a truncated NXF1(117-619)-NXT1 heterodimer that encompasses all annotated domains (NXF1 residues 117-619 and NXT1 residues 1-140). In light of the observation that the flexible linker connecting the RNA-binding domain (RBD) and the effector domain (ED) of NS1 causes structural polymorphism 13, 14 , this linker in NS1(R38A/K41A) was shortened (residues 80-85 replaced by a proline residue) to obtain diffraction-quality crystals. We refer to the resulting NS1 mutant in the text as *NS1 ( Supplementary  Fig. 1 ). Importantly, the *NS1 protein remained competent to bind NXF1-NXT1 (Fig. 2f, lane 6) . The *NS1-NXF1(117-619)-NXT1 complex crystallized in space group P6 5 . The structure was determined by molecular replacement and refined at 3.8 Å resolution with R work and R free values of 23.6% and 28.3%, respectively (where R is the measure of the quality of the structural model obtained from the crystallographic data; Supplementary Fig. 3 and Supplementary Table 1 ). The structure reveals a 2:2:2 complex of *NS1-NXF1(117-619)-NXT1 (Fig. 2a-c) . Two *NS1 molecules dimerize through their RBD domains. The mutated R38 and K41 residues in *NS1 are located in the RBD domain, which does not contact NXF1(117-619)-NXT1 directly. The *NS1 dimer, via the EDs, caps on one end of an elongated platform generated by a domain-swapped dimer of NXF1(117-619)-NXT1. In this domain-swapped dimer, two NXT1 molecules are juxtaposed; the LRR and NTF2L of each NXF1 are connected by a linker that traverses along the surface of both NXT1 molecules. The RNA recognition motif (RRM) and ubiquitin-associated (UBA) domains of NXF1 were not well ordered, and were therefore not built in the present structure. Of note, the elongated NXF1(117-619)-NXT1 platform is symmetrical. Whereas one end of the platform is capped by a NS1 dimer, the other end is unoccupied. It is therefore plausible that another NS1 dimer could bind to the unoccupied end in solution.
The NS1 dimer in the present structure is arranged asymmetrically: two NS1 EDs are oriented differently with respect to the RBD dimer (Fig. 2a-c) . The NS1 dimer makes direct contacts with NXF1(117-619)-NXT1 via both EDs. One ED binds to the NXF1 NTF2L domain (interface I), whereas the other ED binds to the NXF1 LRR domain of the neighbouring NXF1 (interface II). Notably, the observed binding sites are fully consistent with our mapping of the interacting domains in NS1-NXF1-NXT1 (Fig. 1b) . The *NS1-NXF1(117-619)-NXT1 structure shows that the NS1 ED employs two key phenylalanine residues, F103 and F138, to engage NXF1(117-619)-NXT1 (Fig. 2d,e) . The NS1 ED adopts an α-helix β-crescent fold, with the β-strands forming a crescent-like shape around the central α2-helix (Fig. 2d) . Both NS1 ED and NXF1(117-619)-NXT1 do not undergo substantial conformational changes upon interaction 13, 15 . At interface I, F103 on the α1-β2 loop of NS1 ED inserts into a hydrophobic pocket on the NXF1 NTF2L surface generated by conserved residues L383, L386, L491, P521 and L527 ( Fig. 2e and Supplementary Fig. 4 ). At interface II, F138 on the β4-β5 loop of NS1 ED binds to the edge of NXF1 LRR, which is lined by conserved residues K213, M216, Y220, N263 and I264 (Fig. 2e and Supplementary Fig. 4 ). When F103 and F138 of *NS1 were mutated to alanine, individually or in combination ( Supplementary Fig. 5 ), and analysed using in vitro binding assays with NXF1 lacking the NS1-binding site (NXF1 residues 1-110) or full-length NXF1 (residues 1-619), there was marked reduction of the interaction between *NS1 and NXF1-NXT1 (Fig. 2f) . These findings corroborate the structural results regarding the critical role of these NS1 residues in the interaction with NXF1-NXT1. Importantly, F103 and F138 are highly conserved in influenza A virus NS1 proteins, and the majority of strains have at least one of these residues (Supplementary Table 2 ).
Comparison of the *NS1-NXF1(117-619)-NXT1 structure and the previously reported NXF1(NTF2L)-NXT1 in association with a nucleoporin FG peptide reveals that the NS1 ED and FG peptide bind to the same site on NXF1 NTF2L 16 ( Fig. 3a) . This observation suggests that NS1 inhibits binding of FG peptide to NXF1-NXT1. We tested this hypothesis by determining whether NS1 would compete with an FG nucleoporin, Nup98, for NXF1 binding. In vitro transcribed and translated Nup98 was incubated with purified NXF1-NXT1 and increasing concentrations of purified *NS1 or *NS1(F103A/F138A) (Fig. 3b) . Indeed, *NS1 protein displaced Nup98 binding to NXF1 whereas *NS1(F103A/F138A), which did not interact properly with NXF1 (Fig. 2e) , was unable to alter the interaction (Fig. 3b) . We then generated a recombinant influenza virus carrying the same F103A/F138A mutations on NS1 and infected cells with this mutant virus. Cell extracts were analysed by immunoprecipitation with IgG or NXF1 antibodies, followed by western blotting to detect NS1, NXF1 and Nup98 (Fig. 3c) . Again, NS1(F103A/F138A) exhibited reduced interaction with NXF1 in infected cells, compared with wild-type NS1. Similarly, the interaction of the FG nucleoporin Nup153 with NXF1 was diminished in the presence of NS1, and this interaction required the C-terminal FG-repeat domain of Nup153 ( Supplementary Fig. 6 ). These findings demonstrate a key role for NS1 F103 and F138 residues on the interaction with NXF1 in vitro and in infected cells, which prevents NXF1 docking to a subset of FG nucleoporins involved in mRNA nuclear export [17] [18] [19] [20] [21] .
To determine the effect of the virus harbouring NS1(F103A/ F138A) on the intracellular distribution of poly(A) RNA, RNA FISH was performed in infected HBECs to monitor poly(A) RNA and viral M mRNA simultaneously. Both wild-type and mutant viruses did not markedly alter total poly(A) RNA levels ( Fig. 4a and Supplementary Fig. 7a ). The virus harbouring wild-type NS1 induced nuclear retention of poly(A) RNA compared with mockinfected cells, whereas virus harbouring NS1(F103A/F138A)-which is deficient in NXF1 binding-was unable to efficiently block poly(A) RNA in the nucleus, and substantial amounts of poly(A) RNA were exported (Fig. 4a,b) . We also monitored the intracellular Fig. 2 ). Fluorescence intensity of poly(A) RNA was quantified in whole cells (d) or in the nucleus and cytoplasm (e) to determine nuclear-to-cytoplasmic (N/C) ratios. Scale bar, 10 μM. Data in d,e are mean ± s.d. of 50 cells that were counted in three independent experiments. P values were calculated using unpaired, two-tailed Student's t-test.
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Nature Microbiology distribution of individual host mRNAs in A549 cells, which inhibit nuclear export of bulk poly(A) RNA to a lesser extent on infection (Supplementary Table 3 ) compared with HBECs ( Fig. 1c,e) . In A549 cells infected with the influenza virus A/WSN/33 strain (like the Texas strain, a H1N1 virus), 1,223 mRNAs were blocked in the nucleus 6 h after infection, as determined by transcriptome analysis of nuclear and cytoplasmic fractions, and of total cell extracts compared with mock-infected cells (Supplementary Table 3 ). 

Nature Microbiology
Selected mRNA hits were validated by reverse transcription with quantitative PCR (RT-qPCR) in total cell extracts and nuclear and cytoplasmic fractions of A549 cells infected with recombinant virus expressing wild-type NS1 or NS1(F103A/F138A). As shown in Fig. 4c , the total levels of a subset of mRNAs were upregulated by viral infection in both wild-type and mutant viruses. However, the mRNAs blocked in the nucleus during infection by the virus expressing wild-type NS1 were exported in cells infected with virus encoding NS1(F103A/F138A). Of note, NS1 is known to be a multifunctional protein: F103 also contributes to NS1 interaction with the polyadenylation factor CPSF30 22, 23 . As cellular mRNAs have different dynamics during processing, NS1 has differential effects on inhibition of biogenesis, processing and/or nuclear export of individual mRNAs at specific times during infection. For example, at 6 h after infection, the total mRNA levels of selective transcripts such as IFIT2 are not altered by wild-type or mutant viruses (Fig. 4c) . However, IFIT2 mRNA is retained in the nucleus by the wild-type virus and is released in the presence of mutant virus (Fig. 4d) . These results suggest that the total levels of IFIT2 mRNA have not yet been affected by a defect in poly(A) processing via CPSF30, which is likely to target it for degradation, but NS1 has already inhibited nuclear export of IFIT2 mRNA at this time point of infection. Among the mRNAs released by the mutant virus are several that encode antiviral factors or are regulated by interferon, including RIG-I (also known as DDX58) 24 , IFIT2 and IFIT3 25 (Fig. 4d) . As a result of unleashing an antiviral response, viral protein levels In vitro GST pull-down assays with NXF1-NXT1 and *NS1 or *NS1 with mutations on the NXF1-binding site shown in e. Purified GST-NXT1-His-NXF1 was incubated with purified *NS1, *NS1(F103A), *NS1(F138A) or *NS1(F103A/F138A). NS1 was detected by western blot and showed diminished interaction on mutation of the NXF1-binding site. The N-terminal domain of GST-NXF1(1-110) was used as a control. n = 3.
Letters
Nature Microbiology ( Fig. 4e and Supplementary Fig. 7b ) and virus replication (Fig. 4f) are reduced in cells infected with the virus expressing the NS1 mutant deficient in binding to NXF1-NXT1.
In sum, we uncovered the structural and biochemical basis of a key mechanism by which influenza A virus NS1 protein counteracts host antiviral defence. We have established that NS1 targets the principal mRNA export receptor NXF1-NXT1 to block nuclear export of host mRNAs. The crystal structure of NS1-NXF1-NXT1 reveals that NS1 occupies the nucleoporin-binding site on NXF1-NXT1, thereby abrogating the ability of NXF1-NXT1 to escort host mRNAs through the NPC (Fig. 4g) . Because of the critical importance of mRNA nuclear export in eukaryotic gene expression, this pathway is exploited by a broad spectrum of viruses 26 . We show that transcripts of interferon-or immune-regulated genes are among the top transcripts retained in the host nucleus following influenza A infection. Importantly, a mutant virus that is unable to inhibit NXF1-NXT1 is markedly attenuated, reinforcing the importance of inhibition of NS1-mediated host mRNA export in virus replication. Our work thus provides mechanistic insights regarding influenza pathogenesis that may help in development of therapeutic strategies. Table 3 were quantified by RT-qPCR. n = 3. e, Cells were infected as in c except that infection lasted for 8 h. Total cell lysates were analysed by western blotting to detect the depicted proteins. n = 3. f, Cells were infected as in c except that infection was performed for the indicated time points. Viral titres were measured in culture supernatants by plaque assays. n = 3. P values (b-d,f) were calculated using unpaired, two-tailed Student's t-test. PFU, plaque-forming units. g, Model for NS1-mediated inhibition of cellular mRNA nuclear export.
Methods
Reagents
G Sepharose 4 Fast Flow (GE Healthcare, cat. no. 17-0618-01); Hoechst 33258 (Molecular Probes); M mRNA probes (Biosearch Technologies) 27 ; ProLong Gold antifade reagent (Life Technologies, cat. no. P36930).
Antibodies. Influenza A virus NS1 antibody, a gift from J.A. Richt (National Animal Disease Center, Iowa) 28 , was used at a 1:10,000 dilution. β-actin monoclonal antibody (Sigma-Aldrich, clone AC-74, cat. no. A5528) was used at a 1:5,000 dilution. His-tag monoclonal antibody (TAKARA and Clontech, cat. no. 631210) was used at a 1:5,000 dilution. Flag M2 monoclonal antibody (SigmaAldrich, cat. no. F1804) was used at a 1:1,000 dilution. Horseradish peroxidaseconjugated secondary antibodies included donkey anti-rabbit and sheep antimouse (GE Healthcare, cat. nos NA934V and NA931V, respectively). Polyclonal rabbit anti-Nup98
29 was used at a 1:1,000 dilution. Mouse nuclear pore complex proteins antibody MAB414 (Abcam, cat. no. ab24609) was used at a 1:1,000 dilution. Mouse NXF1 antibody (Sigma-Aldrich, cat. no. T1076-200UL) was used at a 1:2,000 dilution. Mouse anti-M2 antibody (Thermo Fisher Scientific, cat. no. MA1-082) was used at a 1:1,000 dilution. Rabbit HA antibody (Genetex, cat. no. GTX127357) was used at a 1:1,000 dilution. Rabbit NA antibody (Genetex, cat. no. GTX125974) was used at a 1:1,000 dilution. Goat influenza A virions antibody (Meridian Life Science, cat. no. B65141G) was used at a 1:1,000 dilution. Mouse IgG (Thermo Fisher Scientific, cat. no. 31903) was diluted to 0.4 mg ml
Cell culture. Human lung adenocarcinoma epithelial cells (A549) were cultured in DMEM supplemented with 10% heat-inactivated fetal bovine serum (Sigma-Aldrich) and penicillin-streptomycin (Gibco). HBECs were cultured in keratinocyte serum-free medium supplemented with human recombinant epidermal growth factor, bovine pituitary extract (Invitrogen), and penicillinstreptomycin. All cells were maintained at 37 °C with 5% CO 2 .
Viruses. Influenza A virus A/WSN/1933 was propagated in MDCK cells and titred as previously described 30 . Influenza viruses expressing either wild-type or mutant (F103A/F138A) NS1 proteins from A/Texas/36/1991 were rescued on an A/Puerto Rico/8/1934 (PR8) backbone and subsequently propagated in MDCK cells after plaque purification. Viral titres were determined by plaque assay in the presence of tosylsulfonyl phenylalanyl chloromethyl ketone (TPCK)-trypsin. Wild-type or mutant NS1 sequences were synthesized from GeneArt Strings DNA fragments (Invitrogen) and cloned into SAPI sites in the pDZ vector. Recombinant influenza viruses, PR8-TX-NS wild-type NS1 and PR8-TX-NS NS1(F103A/F138A), were generated using plasmid-based reverse genetics as previously described 31 . All virus work was performed in strict accordance with the Centers for Disease Control and Prevention guidelines for biosafety level 2.
Plaque assay. A549 cells were infected with PR8-TX-NS wild-type NS1 or PR8-TX-NS NS1(F103A/F138A) at MOI = 2 for 6 h, 8 h, 12 h and 16 h. The culture supernatants were collected and titre was determined by plaque assay, as previously described 30 .
Plasmids. Full-length NS1 (UniProtKB accession number Q9WPI6, residues 1-230) from A/Texas/36/91 was cloned into NotI and BamHI sites of the pMALTEV vector (pMAL with TEV cleavage site) with MBP fusion at the N terminus. A mutant NS1 (UniProtKB accession number I7CAR2, residues 1-230, R38A/K41A, and residues 80-85 replaced by a proline residue), termed *NS1, was cloned into BamHI and NotI sites of a pGEX-4T-1 vector modified to contain a TEV-cleavable N-terminal GST tag. Plasmids GST-*NS1(F103A), GST-*NS1(F138A) and GST-*NS1(F103A/F138A) were generated from the GST-*NS1 template above, using the QuikChange II Site-Directed Mutagenesis Kit. Human NXF1 (UniProtKB accession number Q9UBU9, residues 117-619) was cloned into BamHI and NotI sites of the same modified pGEX-4T-1 vector described above. Full-length human NXT1 (UniProtKB accession number Q9UKK6, residues 1-140) was cloned into NdeI and EcoRI sites of the pBB75 vector for co-expression with NXF1(117-619). Full-length human NXF1 (residues 1-619) was cloned into BamHI and Xhol I sites of the pET32a vector to generate NXF1-His. Full-length human NXT1 was cloned into BamHI and Xhol I sites of pGEX-6P-1 vector to generate GST-NXT1. GST-NXF1(N tail) (residues 1-109), GST-NXF1(RRM) (residues 110-200), GST-NXF1(LRR) (residues 201-371), GST-NXF1(NTF2L) (residues 372-564) and GST-NXF1(UBA) (residues 565-619) were cloned into pGEX-4T-2. Full-length human NXF1 (residues 1-619) and its mutants NXF1(1-200) and NXF1(201-619) were cloned into the XhoI and Smal I sites of the pCIneo-3×Flag vector with the 3×Flag tag at the N terminus, generating plasmids Flag-NXF1, Flag-NXF1(1-200) and Flag-NXF1(201-619). Plasmid encoding Nup98 was generated as described 32 . Full-length human Nup153 (residues 1-1,475) and its mutant Nup153 (residues 1-879) were cloned into the XhoI and Smal I sites of the pCI-neo-3×Flag vector with the 3×Flag tag at the N terminus to generate plasmids encoding Flag-Nup153 and Flag-Nup153(1-879).
Protein expression and purification. GST-*NS1 and GST-NXF1(117-619)-NXT1 were expressed in E. coli Rosetta cells. Protein expression was induced at an optical density at 600 nm of 0.8 with 0.5 mM IPTG at 20 °C and cells were incubated for 16 h. Cells were collected and lysed with a cell disruptor (Avestin) in a wash buffer (50 mM Tris, pH 8.0, 500 mM NaCl, 0.5 mM tris(2-carboxyethyl) phosphine (TCEP)) supplemented with a protease inhibitor mix containing 1 mM PMSF, 5 mg l −1 aprotinin, 1 mg l −1 pepstatin, and 1 mg l −1 leupeptin. Proteins were purified using a glutathione-sepharose column, followed by overnight digestion with TEV protease at 4 °C. *NS1 was applied to a mono Q column and eluted using a 100-300 mM NaCl gradient in a buffer containing 10 mM Tris, pH 8.0. Pooled NS1 fractions were loaded onto a glutathione-sepharose column to remove residual GST that was eluted along with *NS1 on mono Q, recovering *NS1 in the flow through. NXF1(117-619)-NXT1 was applied to a HiTrap SP column and eluted using a 200-400 mM NaCl gradient in a buffer containing 10 mM HEPES, pH 7.0. *NS1 and NXF1(117-619)-NXT1 were further purified using a Superdex 200 column equilibrated with 10 mM HEPES, pH 7.0, 150 mM NaCl, and 0.5 mM TCEP. Purified proteins were concentrated and stored at −80 °C. Purification of GST-*NS1(F103A), GST-*NS1(F138A) and GST-*NS1(F103A/F138A) followed the same protocol as that of GST-*NS1. GST-NXF1(N tail), GST-NXF1(RRM), GST-NXF1(LRR), GST-NXF1(NTF2L), GST-NXF1(UBA), His-NXF1, GST-NXT1, MBP and MBP-NS1 were expressed in BL21(DE3) cells. Protein expression was induced by 0.5 mM IPTG at 16 °C overnight. Bacteria expressing His-NXF1 and GST-NXT1 were harvested together, and were first purified by Ni 2+ ionaffinity chromatography to generate the GST-NXT1His-NXF1 complex. GSTtagged NXF1 domains were first purified by glutathione-affinity chromatography. MBP and MBP-NS1 were first purified by amylose resin. All the proteins were further purified by gel filtration in a buffer containing 20 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 mM DTT and 1x complete protease inhibitor cocktail at pH 7.5.
Crystallization and structure determination. Crystals of *NS1-NXF1(117-619)-NXT1 were obtained at 20 °C by vapour diffusion in sitting drops using 1 µl protein mixture (NXF1(117-619)-NXT1 at 4 mg ml −1 , *NS1 at 8 mg ml
) and 1 µl reservoir solution consisting of 50 mM sodium citrate (pH 5.6), 6.5% polyethylene glycol 3350, 0.1 M NaCl and 0.1 M KCl. The crystals were transferred in three steps of increasing glycerol concentration to a cryoprotectant solution containing 50 mM sodium citrate (pH 5.6), 6.5% PEG 3350, 0.1 M NaCl, 0.1 M KCl and 22% glycerol. X-ray diffraction data were collected at the 21-ID-F Beamline at the Advanced Photon Source, Argonne National Laboratory. The crystals exhibited a long-unit cell axis of ~950 Å, which caused severe overlapping of diffraction spots. To resolve this issue, we adjusted the κ axis to position the crystals in an orientation so that the long axis was approximately parallel to the rotation axis. X-ray intensities were processed using the HKL2000 package 33 . The best diffracting crystal yielded a 3.8-Å-resolution dataset in space group P6 5 .
The asymmetric unit contains two copies of a 2:2:2 complex of *NS1-NXF1(117-619)-NXT1. Initial electron density map was obtained by molecular replacement using the coordinates of NXF1-NXT1 (PDB ID 4WYK for the NXF1 NTF2L domain and NXT1; 3RW6 for the NXF1 LRR domain) and NS1 (PDB ID 4OPA for NS1 RBD and NS1 ED) as search models in Phaser 34 . The structure was built with Coot 35 and refined with phenix.refine 36 . NCS restraints, secondary structure restraints, Ramachandran restraints and TLS (with each of the NS1 RBD, NS1 ED, NXF1 LRR, NXF1 NTF2L and NXT1 domains assigned to one group) were applied during the refinement. The *NS1-NXF1(117-619)-NXT1 complex consists of NXF1 (residues 205-423 and 430-549), NXT1 (residues 3-140) and NS1 (residues 2-72 and 88-202 for one molecule; residues 8-45, 88-136 and 142-202 for the other molecule). In the *NS1-NXF1(117-619)-NXT1 structure, NS1 molecules exhibit higher B factors than NXF1 and NXT1 molecules. In particular, the NS1 RBD dimer appears to be largely positioned by crystal packing. It is notable that a helix (residues 46-72) belonging to the yellow RBD (Fig. 2b) is not observed in the structure. Potential steric clashes between this helix and a symmetry-related molecule due to crystal packing is likely to have caused deviation of this helix from the expected position. Details of the data collection and refinement statistics are listed in Supplementary Table 1. Molecular graphics were rendered using PyMOL (http://www.pymol.org/; Schrödinger).
GST pull-down assays. GST or GST-NXT1-His-NXF1, or GST-tagged NXF1 domains were incubated with MBP or MBP-NS1; and GST-NXF1(1-110) or GST-NXT1-His-NXF1 were incubated with *NS1 or its mutants (*NS1(F103A), *NS1(F138A) or *NS1(F103A/F138A)) in binding buffer (20 mM Tris, 150 mM NaCl, 1 mM DTT, 1 mM EDTA, pH 7.5) at room temperature for 30 min. Each protein (1 µM) was loaded into the binding assay. Beads were pelleted by centrifugation at 5,000 r.p.m. for 5 min and washed five times with 1 ml of binding buffer. Proteins remaining on the resin were extracted with sample buffer, resolved by SDS-PAGE and then detected by western blot using NS1 antibody.
In vitro binding assays with Nup98 and Nup153. Nup98 protein (UniProtKB accession number P52948) was generated by in vitro transcription and translation using a coupled reticulocyte lysate transcription-translation system in the presence of [ 35 S]methionine, according to the manufacturer's instructions. Binding reactions between Nup98 and NXF1-NXT1 were carried out using 25 µl of in vitro transcribed and translated proteins and 2 µM GST-NXT1-His-NXF1 recombinant protein. Increasing amounts (2 µM, 4 µM and 8 µM) of *NS1 or *NS1(F103A/ F138A) were added to the binding assay. Bound and unbound fractions were subjected to SDS-PAGE followed by autoradiography.
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Flag-Nup153 (UniProtKB accession number P49790) or Flag-Nup153(1-879) proteins were expressed in the rabbit reticulocyte lysate as in the case Nup98 except that they were detected by western blot using Flag antibody. Binding reactions between Nup153 or Nup153(1-879) and NXF1-NXT1 were carried out using 25 µl of in vitro transcribed and translated proteins and 2 µM GST-NXT1-His-NXF1 recombinant proteins. Increasing amounts (2 µM and 8 µM) of *NS1 were added to the binding assay. Bound and unbound fractions were subjected to SDS-PAGE followed by western blot using Flag antibody.
Immunoprecipitation and immunoblot. A549 cells grown in 10 cm plates were non-infected or infected with PR8-TX-NS NS1 wild-type virus or PR8-TX-NS NS1(F103A/F138A) virus for 6 h. Cells were lysed for 30 min at 4 °C in the following buffer: 50 mM Tris, pH 7.5, 150 mM NaCl, 1% IGEPAL CA-630, 0.1 mM Na 3 VO 4 , 1 mM NaF, 1 mM DTT, 1 mM EDTA, 1 mM PMSF, 1× complete protease inhibitor cocktail and 10% glycerol. Cell lysates were centrifuged at 13,000g for 10 min to remove cellular debris. The supernatant was applied to protein G beads bound to either mouse IgG or mouse NXF1 antibody and incubated for 4 h at 4 °C. After five washes with lysis buffer, the proteins were eluted with 2× sample buffer and subjected to 8% SDS-PAGE.
Cell fractionation. A549 cells were infected with PR8-TX-NS NS1 wild-type virus or PR8-TX-NS NS1(F103A/F138A) virus for 6 h. Cells were collected by trypsinization and transferred to 15 ml conical tubes on ice, washed three times with cold PBS and then transferred to microfuge tubes. Cells were fractionated using NE-PER Nuclear and Cytoplasmic Extraction Reagents according to the manufacturer's instructions.
Transcriptome analysis. A549 cells were infected with influenza virus A/WSN/1933 at an MOI of 5 for 6 h. RNA of total cells, nuclear fraction or cytoplasmic fraction was prepared using RNeasy Plus mini Kit. Purified RNA was quantified by Nanodrop (Thermo Fisher). The RNA samples were subjected to transcriptome analysis using Illumina Human BeadChip 22k according to the manufacturer's instructions.
RT-qPCR.
Total RNA (1 µg) was used to generate complementary DNA by reverse transcription using SuperScript II reverse transcriptase. cDNA was diluted at a ratio of 1:5. cDNA samples were mixed with specific primers and Roche 480 SYBR Green I Master real-time PCR reagents, and were subjected to quantitative realtime PCR (qPCR) using the Roche LightCycler 480 system. The program used for real-time PCR is the same as previously reported 2 . Relative RNA concentration was calculated by the ΔΔC t method and compared with β-actin control. Primer sequences used in this study are as follows (5′ to 3′):
β-actin (NCBI accession number NM_001101.5; forward: CCGCGAGAAGATGACCCAGAT, reverse: CGTTGGCACAGCCTGGATAGCAACG); PPBP (NCBI accession number NM_002704.3; forward: TCCTCCACCAAAGGACAAAC, reverse: CCATCCTTCAGTGTGGCTATC); IFIT3 (NCBI accession number NM_001549.6; forward: TCAGAAGTCTAGTCACTTGGGG, reverse: ACACCTTCGCCCTTTCATTTC); IFIT2 (NCBI accession number NM_001547.5; forward: GACACGGTTAAAGTGTGGAGG, reverse: TCCAGACGGTAGCTTGCTATT); PRIM2 (NCBI accession number NM_000947.5; forward: CGGCTTGCTTATTGCCAGTCT, reverse: CAATCTCCTGTTCTCGAAGAGTC); RIG-I (NCBI accession number NM_014314.4; forward: ACGGGTGTATGCGCTTCAC, reverse: TTGCGGTCATCGAACAGGG); MAP1A (NCBI accession number NM_002373.6; forward: GCTGAGTTCTCCGAGTATGTCT, reverse: TGAGTAGCACCGAGTCAATGC); CD47 (NCBI accession number NM_001777.3; forward: AGAAGGTGAAACGATCATCGAG, reverse: CTCATCCATACCACCGGATCT).
Western blot. A549 cells were mock-infected or infected with PR8-TX-NS NS1 wildtype, or PR8-TX-NS NS1(F103A/F138A) for 8 h at MOI = 2, lysed in 2× sample buffer and subjected to 10% SDS-PAGE. Western blot was performed with the following primary antibodies: rabbit HA antibody, rabbit NA antibody, goat M1 antibody, rabbit NS1 antibody and mouse M2 antibody. Proteins were visualized in the LI-COA system and quantified using imageJ64. The UniProtKB accession numbers for HA, NA, M1 and M2 are B4UPA6, G1UK16, P03485 and Q84028, respectively. RNA FISH and immunofluorescence microscopy. In Fig. 1c,d , HBECs were transfected with pcI-neo-3×Flag vector, Flag-NXF1, Flag-NXF1(1-200) or Flag-NXF1(201-619) for 48 h, and ~20% of cells were infected with influenza virus A/WSN/33 for 30 h. The samples were then analysed by RNA FISH and immunofluorescence microscopy using Flag antibody, as previously described 27 . In Fig. 4a ,b, ~100% of HBEC cells were infected with PR8-TX-NS NS1 wild-type or PR8-TX-NS NS1(F103A/F138A) for 30 h. Cells were then analysed by RNA FISH as described 27 . Circular dichroism. Circular dichroism (CD) spectra were collected using 12 μM of recombinant NS1 proteins (*NS1, *NS1(F103A), *NS1(F138A) and *NS1(F103A/F138A)), in CD buffer (20 mM sodium phosphate pH 8.0, 50 mM NaF and 0.5 mM TCEP). The spectra were collected in the far-UV range (250-190 nm) on a Jasco-815 CD spectrometer in 1 mm path-length cuvette at a scanning rate of 50 nm min −1 at 0.1 nm intervals. The final CD spectrum for each sample was obtained by averaging six repeat scans. The resulting spectra are plotted as molar ellipticity against wavelength.
Statistical analysis. Statistical analyses were performed using the two-sample, two-tailed t-test assuming equal variance. For statistical analysis of the M mRNA imaging study, a minimum of 50 cells were used for analysis in each condition. For all imaging studies, a one-sample Kolmogorov-Smirnov test was conducted. A normal distribution was assumed for all populations (P > 0.05).
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
The coordinates of the NS1-NXF1-NXT1 structure have been deposited in the Protein Data Bank under accession number 6E5U. The data for the transcriptome analysis has been deposited in the Gene Expression Omnibus under accession number GSE129318. All other data that support the findings of this study are available from the corresponding authors upon request. 
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